Lexaria Bioscience (LEXX, Financial), a Canadian pharmaceutical company, saw its stock fall by 27.4% in early trading. The decline followed the company's announcement to terminate its $5 million stock sales agreement with JonesTrading.
Lexaria Bioscience (LEXX, Financial), a Canadian pharmaceutical company, saw its stock fall by 27.4% in early trading. The decline followed the company's announcement to terminate its $5 million stock sales agreement with JonesTrading.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.